NR1H4 and cystic fibrosis: This finding was validated in CF organoid models, where exogenous bile acid stimulation successfully restored FXR activity, confirming the pivotal role of the “gut microbiota–bile acid–FXR” axis in CF-associated hepatobiliary complications.